Serotonin 5-HT2C Receptor Neurons

Serotonin 5-HT2C Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Serotonin 5-HT2C Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Serotonin Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Choroid plexus, [Cortex](/brain-regions/cortex), Hypothalamus, Basal ganglia</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>5-HT2C (HTR2C)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gq-coupled, phospholipase C activation</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>HTR2C (Xq24)</td>
</tr>
</table>

Serotonin 5 Ht2C Receptor [Neurons](/entities/neurons) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Serotonin 5-HT2C receptor neurons represent a critical subpopulation of serotonergic neurons that express the 5-HT2C subtype of serotonin receptor[@stahl2009]. These neurons play essential roles in regulating mood, appetite, motor control, and have significant implications for neurodegenerative diseases including Alzheimer's Disease (AD) and Parkinson's Disease (PD). [@niswender2001]

Overview

Serotonin 5-HT2C Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Serotonin 5-HT2C Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Serotonin Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Choroid plexus, [Cortex](/brain-regions/cortex), Hypothalamus, Basal ganglia</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>5-HT2C (HTR2C)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gq-coupled, phospholipase C activation</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>HTR2C (Xq24)</td>
</tr>
</table>

Serotonin 5 Ht2C Receptor [Neurons](/entities/neurons) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Serotonin 5-HT2C receptor neurons represent a critical subpopulation of serotonergic neurons that express the 5-HT2C subtype of serotonin receptor[@stahl2009]. These neurons play essential roles in regulating mood, appetite, motor control, and have significant implications for neurodegenerative diseases including Alzheimer's Disease (AD) and Parkinson's Disease (PD). [@niswender2001]

Overview

Molecular Properties

Receptor Structure

• Family: 5-HT2 (Gq/11 family)
• Protein: 7-transmembrane domain GPCR
• RNA editing: Multiple isoforms (A, B, C, D, E, F, VNV) - edited versions show reduced signaling[@niswender2001]
• Dimerization: Can form homomers and heteromers with other 5-HT2 receptors
• Post-translational modifications: N-glycosylation, palmitoylation

Distribution in the Brain

• Choroid plexus: Highest density - regulates cerebrospinal fluid secretion
• Hypothalamus: Paraventricular nucleus (PVN) and arcuate nucleus (Arc) - regulate feeding behavior
• Cortex: Layer-specific expression in pyramidal neurons
• Basal ganglia: Striatum and substantia nigra - motor control
• [Hippocampus](/brain-regions/hippocampus): CA1-CA3 regions - cognition and memory

Functions

Neuroendocrine Regulation

Feeding Behavior

• Satiety signaling: 5-HT2C receptor activation in the hypothalamus induces satiety[@stahl2009]
• POMC neurons: 5-HT2C expressed on proopiomelanocortin neurons
• NPY/AgRP: Inhibition of neuropeptide Y/agouti-related peptide orexigenic neurons
• Energy homeostasis: Integration with leptin and insulin signaling
• Clinical relevance: 5-HT2C agonists reduce food intake and body weight

Mood and Psychiatric Effects

• Depression: 5-HT2C receptor antagonists may have antidepressant-like effects
• Anxiety: Complex bidirectional regulation - both agonists and antagonists show anxiogenic potential
• Antipsychotic drugs: Many atypical antipsychotics antagonize 5-HT2C
• SSRI effects: Chronic SSRI use leads to 5-HT2C desensitization

Motor Control

• Basal ganglia circuitry: 5-HT2C in striatal medium spiny neurons
• Parkinson's disease: Altered 5-HT2C receptor expression and signaling[@higgins2020]
• Levodopa-induced dyskinesia: 5-HT2C antagonists reduce dyskinesias in animal models
• Therapeutic targeting: 5-HT2C modulation as adjunct to dopaminergic therapy

Role in Neurodegenerative Diseases

Alzheimer's Disease

Amyloid and Tau Pathology

• 5-HT2C and amyloid: Studies suggest 5-HT2C activation may modulate [amyloid precursor protein](/entities/app-protein) (APP) processing
• [Tau](/proteins/tau) phosphorylation: 5-HT2C signaling can influence tau pathology through various kinases
• Neuronal survival: 5-HT2C activation provides neuroprotective effects against [Aβ](/proteins/amyloid-beta) toxicity

Neuroinflammation

• Microglial modulation: 5-HT2C on [microglia](/cell-types/microglia-neuroinflammation) influences neuroinflammatory responses
• Cytokine production: Modulates IL-1β, TNF-α, and IL-6 release
• Therapeutic potential: 5-HT2C agonists may reduce neuroinflammation

Cognitive Function

• Hippocampal plasticity: 5-HT2C modulates hippocampal synaptic plasticity
• Learning and memory: Loss of 5-HT2C signaling associated with cognitive deficits
• Aging: Age-related changes in 5-HT2C expression

Parkinson's Disease

Motor Complications

• Levodopa-induced dyskinesia (LID): 5-HT2C antagonists reduce LID in preclinical models[@higgins2020]
• Nigrostriatal pathway: Altered 5-HT2C expression in PD substantia nigra
• Therapeutic strategy: 5-HT2C inverse agonists as anti-dyskinetic agents

Non-Motor Symptoms

• Depression: High comorbidity in PD - 5-HT2C modulation relevant
• Sleep disorders: 5-HT2C in circadian rhythm regulation
• Weight changes: Appetite dysregulation in PD

Other Neurodegenerative Conditions

Huntington's Disease

• Striatal degeneration: 5-HT2C loss in Huntington's disease striatum
• Behavioral symptoms: 5-HT2C modulation affects chorea and irritability
• Neuroprotection: 5-HT2C agonists show promise in preclinical models

Amyotrophic Lateral Sclerosis (ALS)

• Motor neuron vulnerability: 5-HT2C on motor neurons
• Excitotoxicity: Modulation of glutamatergic signaling
• Clinical trials: 5-HT2C-targeted therapies under investigation

Therapeutic Targeting

Agonists

• Lorcaserin: Former obesity drug - selective 5-HT2C agonist
• Vabicaserin: Full 5-HT2C agonist
• Clinical applications: Obesity, potential for PD dyskinesia

Antagonists

• Agomelatine: MT1/MT2 melatonin + 5-HT2C antagonist (antidepressant)
• Atypical antipsychotics: Risperidone, olanzapine, clozapine
• Anti-dyskinetic potential: For PD levodopa-induced dyskinesia

Allosteric Modulators

• Positive allosteric modulators: Under development
• Therapeutic advantages: More nuanced receptor modulation

Summary

Serotonin 5-HT2C receptor neurons represent a pivotal population in understanding neurodegenerative disease mechanisms. Their roles in modulating feeding, mood, motor control, and neuroinflammation make them attractive therapeutic targets. The development of selective 5-HT2C ligands offers potential for treating various aspects of AD, PD, HD, and ALS, particularly motor complications in Parkinson's disease.

See Also

• [Serotonin 5-HT3 Receptor Neurons](/cell-types/serotonin-5-ht3-receptor-neurons)
• [Serotonin 5-HT1A Receptor Neurons](/cell-types/serotonin-5-ht1a-receptor-neurons)
• [Serotonin Neurotransmission](/cell-types/serotonin-neurotransmission)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Huntington's Disease](/diseases/huntington-disease)
• [Basal Ganglia Circuitry](/cell-types/basal-ganglia-circuitry)
• [Hypothalamic Neurons](/cell-types/hypothalamic-neurons)

External Links

• [Wikipedia: 5-HT2C Receptor](https://en.wikipedia.org/wiki/5-HT2C_receptor)
• [IUPHAR: HTR2C](https://www.guidetopharmacology.org/GRPC/RXNB2)
• [NCBI Gene: HTR2C](https://www.ncbi.nlm.nih.gov/gene/3358)

Background

The study of Serotonin 5 Ht2C Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Serotonin 5-HT2C Receptor Neurons discovered through SciDEX knowledge graph analysis: